GenSight Biologics S.A.
SIGHT.PA · PAR
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | €2 | €2 | €11 | €44 |
| Short-Term Investments | €0 | €0 | €0 | €0 |
| Receivables | €0 | €0 | €3 | €1 |
| Inventory | €0 | -€0 | €8 | €4 |
| Other Curr. Assets | €3 | €4 | €0 | €4 |
| Total Curr. Assets | €5 | €7 | €23 | €53 |
| Property Plant & Equip (Net) | €1 | €2 | €2 | €3 |
| Goodwill | €0 | €0 | €0 | €0 |
| Intangibles | €0 | €0 | €0 | €0 |
| Long-Term Investments | €4 | €1 | €1 | €0 |
| Tax Assets | €0 | €0 | -€1 | €0 |
| Other NC Assets | €0 | €0 | €1 | €1 |
| Total NC Assets | €5 | €3 | €3 | €3 |
| Other Assets | €0 | €0 | €0 | €0 |
| Total Assets | €11 | €9 | €26 | €57 |
| Liabilities | – | – | – | – |
| Payables | €6 | €6 | €8 | €12 |
| Short-Term Debt | €14 | €17 | €2 | €5 |
| Tax Payable | €0 | €0 | €0 | €0 |
| Deferred Revenue | €0 | €0 | €0 | €0 |
| Other Curr. Liab. | €2 | €2 | €4 | €5 |
| Total Curr. Liab. | €23 | €25 | €15 | €22 |
| LT Debt | €5 | €6 | €10 | €7 |
| Deferred Rev, NC | €0 | €0 | €0 | €0 |
| Deferred Tax Liab, NC | €0 | €0 | €0 | €0 |
| Other NC Liab. | €10 | €8 | €11 | €6 |
| Total NC Liab. | €15 | €15 | €27 | €18 |
| Other Liabilities | €0 | €0 | €0 | €0 |
| Cap. Leases | €1 | €2 | €2 | €2 |
| Total Liabilities | €38 | €40 | €41 | €41 |
| Equity | – | – | – | – |
| Pref Stock | €0 | €197 | €0 | €138 |
| Common Stock | €3 | €2 | €1 | €1 |
| Retained Earnings | -€14 | -€26 | -€28 | -€29 |
| AOCI | -€223 | -€197 | -€170 | -€138 |
| Other Equity | €207 | -€6 | €11 | €43 |
| Total Equity | -€27 | -€31 | -€15 | €16 |
| Supplemental Information | – | – | – | – |
| Minority Interest | €0 | €0 | €0 | €0 |
| Total Liab. & Tot. Equity | €11 | €9 | €26 | €57 |
| Net Debt | €17 | €21 | €2 | -€32 |